High PLOD1 expression levels were found in gastrointestinal carcinoma (Wang et al., 2018), osteosarcoma (Jiang et al., 2020), glioma (Tian et al., 2021; Wang et al., 2021) and bladder cancer (Yamada et al., 2019). This evidence concerns the gene PLOD1 and central nervous system cancer.